Network meta-analysis of 113 RCTs (20,666 participants) in acute bipolar mania: many drugs and doses, including risperidone, haloperidol, olanzapine, lithium and valproate, cut manic symptoms vs placebo; no significant differences for response, acceptability or tolerability.
Meta-analysisn = 20,666
Fornaro et al. Efficacy, acceptability, and related outcomes of pharmacological interventions for acute bipolar mania: a systematic review and dose-related network meta-analysis across different age groups